维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

11篇 您的检索式：作者名="Temel JS"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Early palliative care for patients with metastatic non-small-cell lung cancer显示文摘Comments This landmark article demonstrates that integration of early palliative care with standard oncologic practice shortly after diagnosis may improve quality of life,mood,and overall survival for adults with advanced non-small-cell lung cancer(NSCLC).If validated,these findings could support a paradigm shift in the care of adults with metastatic NSCLC and possibly patients with other tumor types characterized by short survival and high symptom burden.	Temel JS Greer JA Muzikansky A Gallagher ER Admane S Jackson VA Dahlin CM Blinderman CD Jacobsen J Pirl WF Billings JA Lynch TJ	2010	中国肺癌杂志2010，13，9：	165
	2	Compared with aeyl-CoA: cholesterol acyltransferase (ACAT) 1 and lecithin : cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol显示文摘	Temel RE Gebre AK Parks JS	2003	J Biol Chem2003，278，47：	1
	3	Enhancement of SR-BI-mediated cholesteryl ester selective uptake from apoA -Ⅰ(-/-)HDL by apoA -Ⅰ requires HDL reorganization by LCAT显示文摘	Temel RE Parks JS Williams DL	2003	Biol Chem2003，278，5：	1
	4	Compared with acyl-CoA:cholesterol O-acyhransferase(ACAT)1 and lecithin:cholesterol acyltransferase,ACAT2 displays the greatest capacity to differentiate cholesterol from sitoster-ol显示文摘	Temel RE Gebre AK Parks JS et a1	2003	J Biol Chem2003，278，47：	1
	5	Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer? 显示文摘	Shi AA Digumarthy SR Temel JS	2006	J Thorac Oncol2006，1，：	1
	6	Enhancement of scavenger receptor class B type I-mediated selective cholesterol ester uptake from apoA-I-/-high density lipoprotein (HDL) by apolipoprotein A-I requires HDL reorganization by lecithin cholesterol acyltransferase显示文摘	Temel RE Parks JS Williams DL	2003	J Biol Chem2003，278，7：	1
	7	Aggressiveness of care in a prospective cohort of patients with advanced NSCLC 显示文摘	Temel JS McCannon J Greer JA	2008	Cancer2008，113，4：	1
	8	Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer?显示文摘	Shi AA Digumarthy R Temel JS	2006	J Thorac Oncol2006，1，3：	1
	9	Depression after diagno- sis of advanced non-small cell lung cancer and survival:a pilot study显示文摘	Pirl WF Temel JS Billings A	2008	Psychosomatics2008，49，3：	1
	10	Using the differential from complete blood counts as a biomarker of fatigue in advanced non-small-cell lung cancer: an exploratory analysis显示文摘	Paddison JS Temel JS Fricchione GL	2009	Palliat Support Care2009，7，2：	1
	11	A phase II study of oxaliplatin,pemetrexed,and bevaci-zumab in previously treated advanced non-small cell lung cancer显示文摘	Heist RS Fidias P Huberman M Ardman B Sequist LV Temel JS Lynch TJ	2008	J Thorac Oncol2008，3，10：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费